[1]JustusLiebigsAnnalenderChemie,1918,vol.417,p.75
[2]JournaloftheAmericanChemicalSociety,1991,vol.113,#25,p.9630-9639
[3]Patent:EP3196191,2017,A1,.Locationinpatent:Paragraph0053;0054
[1]AdvancedSynthesisandCatalysis,2018,vol.360,#18,p.3544-3552
[1]Tetrahedron,1999,vol.55,#44,p.12907-12928
[2]JournalofMedicinalChemistry,1981,vol.24,#4,p.382-389
[1]JournalofMedicinalChemistry,2003,vol.46,#19,p.4104-4112
[1]JournaloftheAmericanChemicalSociety,1991,vol.113,#25,p.9630-9639
[1]ChemischeBerichte,1902,vol.35,p.901
[1]PhilosophicalTransactionsoftheRoyalSocietyofLondon,1948,vol.<A>241,p.147,188
[2]JournaloftheChemicalSociety.PerkintransactionsI,1974,p.2339-2342
[1]JournalfurpraktischeChemie(Leipzig1954),1910,vol.<2>82,p.539
[1]ChemischeBerichte,1898,vol.31,p.2640
[1]MonatsheftefurChemie,1914,vol.35,p.332 MonatsheftefuerChemie,1915,vol.36,p.6
Title: Using fragment cocktail crystallography to assist inhibitor design of Trypanosoma brucei nucleoside 2-deoxyribosyltransferase.
Journal: Journal of medicinal chemistry 20061005